An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.
Aminoimidazole Carboxamide has been studied across 16 research domains including 🔬 Oncology, 🔥 Metabolic, 🏃 Endurance & VO2, 🫁 Liver & Detox, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 31% of studies addressing this area.
The following compounds share molecular targets with Aminoimidazole Carboxamide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Aminoimidazole Carboxamide is generated deterministically from 121 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.